BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15590200)

  • 21. Should pelvic lymph node dissection be performed with radical prostatectomy? No.
    Cookson MS
    J Urol; 2010 Apr; 183(4):1284-5. PubMed ID: 20171675
    [No Abstract]   [Full Text] [Related]  

  • 22. Should pelvic lymph node dissection be performed with radical prostatectomy? Yes.
    Studer UE
    J Urol; 2010 Apr; 183(4):1285-7. PubMed ID: 20181363
    [No Abstract]   [Full Text] [Related]  

  • 23. A marginal issue: in regard to Wolden et al. (Int J Radiat Oncol Biol Phys 2005;61:1432-1438).
    Scarbrough TJ; Thomas CR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):647-8; author reply 648-9. PubMed ID: 16168860
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to "Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy" (Int J Radiat Oncol Biol Phys 2009, in press).
    Froehner M; Koch R; Litz RJ; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1274. PubMed ID: 20206022
    [No Abstract]   [Full Text] [Related]  

  • 25. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 26. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinicopathological evaluation of radical retropubic prostatectomy-positive outcome even at institutes with relatively limited experience.
    Okamura T; Akita H; Tozawa K; Kohri K
    Hinyokika Kiyo; 2007 Aug; 53(8):533-6; discussion 537. PubMed ID: 17874543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
    Williams S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
    [No Abstract]   [Full Text] [Related]  

  • 32. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
    Kelly P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
    [No Abstract]   [Full Text] [Related]  

  • 34. In regards to Roach et al. defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference (Int J Radiat Oncol Biol Phys 2006;65:965-974).
    Cheung R
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1274; author reply 1274-5. PubMed ID: 17145548
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 36. In regard to D'Amico et al.: predictors of mortality after prostate-specific antigen failure (Int J Radiat Oncol Biol Phys 2006;65:656-660).
    Williams S
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1598; author reply 1598-9. PubMed ID: 17126225
    [No Abstract]   [Full Text] [Related]  

  • 37. TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759).
    Langsenlehner T; Kapp KS; Langsenlehner U
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):960; author reply 960-1. PubMed ID: 18514790
    [No Abstract]   [Full Text] [Related]  

  • 38. Morbidity of modified pelvic lymphadenectomy and external beam radiation therapy for prostatic cancer.
    Brausi M; Soloway MS
    Prog Clin Biol Res; 1990; 357():145-9. PubMed ID: 2217457
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 40. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Cheung MR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.